OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.
By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.
Lys-Glu-Asp-Ala (KEDA). Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: limited.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Low | 1 mg | daily ×10 days | 0.05 mL | 5 u | 20 doses | |
| Standard | 5 mg | daily ×10 days | 0.25 mL | 25 u | 4 doses | |
| Upper | 10 mg | daily ×10 days | 0.5 mL | 50 u | 2 doses |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial | |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 1 mg | daily | 0.05 mL | 5 u | 14 | 14 mg |
| Weeks 3–4 | 5 mg | daily | 0.25 mL | 25 u | 14 | 70 mg |
| Week 5 onward per 4 weeks from here on |
10 mg | daily | 0.5 mL | 50 u | 28 | 280 mg |
Bioregulator tetrapeptide associated with hepatic and chromatin-decondensation claims. Same evidence caveats as the rest of the class.
Buy Livagenthis peptideOpens optimal-pep.com in a new tab
Browse the full catalogue, or jump to a neighbouring compound.
A dipeptide bioregulator associated with thymic and immune claims within the same Russian research programme.…
Bioregulator peptide directed at cartilage and connective tissue in the Khavinson framework. No independent clinical literature.…
Every compound compared in one table: dose range, how often, half-life and evidence tier.